ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients With Pulmonary Arterial Hypertension (PAH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00310830
Recruitment Status : Terminated (Slow enrollment)
First Posted : April 5, 2006
Last Update Posted : February 15, 2010
Sponsor:
Information provided by:
Actelion

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : August 2007
  Actual Study Completion Date : August 2007
  Certification/Extension First Submitted : February 11, 2010